VA Salt Lake City Health Care System
Below are studies currently enrolling
- Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination with Ruxolitinib in Subjects with Myelofibrosis
- S1712, A Randomized Phase II Study of Ruxolitinib (NSC-752295) in Combination with BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia (CML) Patients with Molecular Evidence of Disease
- Infectious Disease
- Internal Medicine
To advance the health and care of Veterans through collaborative research studies that produce innovative and effective solutions to national healthcare problems.